Physician-led clinical trials at seven Rejuvenation sites across Canada.
The team supports industry-sponsored and investigator-initiated trials across a broad range of indications, collaborating closely with sponsors, CROs, investigators and ethics boards to deliver high-quality data while maintaining a strong commitment to patient safety.
Since its inception, the division has evolved from a single research-focused clinic into a coordinated, multi-province research network. Today it operates with standardized infrastructure, centralized oversight and experienced investigators across Canada.
Rejuvenation Dermatology connects patients, physicians and sponsors through a national network facilitating clinical trials. Each one enters the same system of standardized infrastructure, centralized oversight and experienced investigators.
Access investigational therapies that are not yet commercially available, with all study-related treatments, assessments and visits provided at no cost to eligible participants and close oversight by experienced dermatologists. Trials are open to existing patients and the public, and a referral is not required.
For patients →Board-certified dermatologists and physicians lead every study as investigators, supported by trained research staff and strict Good Clinical Practice standards. Participation keeps Rejuvenation physicians at the forefront of dermatologic innovation and brings new therapies to their patients earlier.
Meet our investigators →A fully integrated, multi-site network with centralized oversight, standardized systems for regulatory submissions, data collection and quality control, and experience across every phase from Phase I safety studies to Phase IV post-marketing research.
For sponsors →The department partners with global pharmaceutical sponsors and CROs on industry-sponsored and investigator-initiated trials, delivering consistent execution and audit-ready data across all sites.
Our investigators conduct industry-sponsored and investigator-initiated trials across a broad range of dermatologic indications. Select a condition to learn about the research we conduct, or see what is currently open.
Clinical research at Rejuvenation Dermatology is driven by a commitment to advance patient care through evidence-based medicine. By participating in regulated clinical trials, the organization helps shape the development of safer, more effective dermatologic treatments while ensuring patients receive care that meets the highest ethical and scientific standards.
Participation in clinical research enables Rejuvenation physicians to remain at the forefront of dermatologic innovation and provides patients with access to therapies that may not yet be commercially available.
By integrating research directly into clinical practice, we evaluate new therapies in real-world settings while maintaining the highest medical standards: patients access innovative treatments earlier, and the data we generate reflects how therapies perform in everyday care.
Every site shares the same standardized infrastructure, centralized oversight and quality systems, so sponsors get consistent execution whether a study runs at one location or all seven.
Our investigators and coordinators bring decades of combined experience across therapeutic areas, delivering high-quality data on time with consistent performance and reliable execution at scale.
All sites are equipped to support trials of any complexity, with dedicated exam rooms, specialized lab capabilities and purpose-built offices meeting the highest operational and compliance standards.
We operate on advanced clinical platforms including eCTMS, eSource and eDocs to optimize study performance, and fully support remote monitoring for seamless oversight and efficient execution.
Targeted recruitment strategies and a broad patient network across Canada ensure reliable enrolment, while a patient-first approach builds trust and retention to keep studies progressing on schedule.
All regulatory operations are managed in house to ensure full compliance and faster timelines, supported by deep expertise in both local and central ethics submissions across diverse study types.
A nationwide network provides broad reach and access to diverse populations, enabling faster start-up, stronger enrolment and consistent delivery across regions with dependable study performance.
Rejuvenation Dermatology’s Clinical Trials Division operates across a network of strategically located sites in Calgary, Edmonton, Vancouver and Oakville, providing broad geographic reach and access to diverse patient populations across Canada. Each location is fully equipped with dedicated clinical research infrastructure and experienced staff, ensuring consistent study execution, high-quality data collection and seamless coordination across all sites.
Coventry Hills Centre
View site →
Southland Park plaza, off Macleod Trail
View site →
Our newest Alberta research site
View site →
First Edmonton Place, Jasper Avenue
View site →
Ambleside, Windermere Boulevard
View site →
Flagship research site in the heart of Vancouver
View site →
Our first Ontario location
View site →Our team of physicians consists of experienced, board-certified dermatologists actively involved in clinical research across a wide range of skin conditions. With a strong foundation in both medical and cosmetic dermatology, they bring clinical expertise, research rigor and a commitment to advancing evidence-based care. Each investigator adheres to strict Good Clinical Practice standards, ensuring patient safety, protocol compliance and high-quality data at every stage of the study.
Our clinical research team consists of experienced coordinators, nurses, research professionals and operational staff dedicated to advancing dermatologic research across a wide range of skin conditions. With diverse backgrounds in healthcare, clinical operations, laboratory science, epidemiology and patient care, the team brings a collaborative, patient-centered approach to every study.
Clinical trials are open to both existing Rejuvenation Dermatology patients and members of the public, and a referral is not required. Eligibility is determined by study-specific criteria, which may include age, medical history, current health status, the type and severity of your condition, and previous or ongoing treatments. Each study follows strict inclusion and exclusion guidelines to protect patient safety and the integrity of the research.
Contact our research team through the form on this page or by email. A member of the research team will connect with you, conduct an initial pre-screening discussion and assess your eligibility for current or upcoming studies. The process is designed to be efficient, informative and tailored to your individual circumstances.
No. All study-related treatments, assessments and visits are provided at no cost to eligible participants. Reimbursement may also be available for reasonable participation-related expenses such as travel, parking and time off work, in accordance with ethics board guidelines.
Our investigators conduct trials in acne, alopecia areata, atopic dermatitis, chronic hand eczema, hidradenitis suppurativa, lichen simplex chronicus, lupus-related skin conditions, prurigo nodularis, psoriasis, ulcerative pyoderma gangrenosum, urticaria and vitiligo. Visit the Studies page for what is currently open.
Seven sites across three provinces: Calgary North, Calgary South and Calgary West in Alberta, Edmonton Downtown and Edmonton South in Alberta, Coal Harbour in Vancouver, British Columbia, and Oakville, Ontario. Each location has dedicated clinical research infrastructure and experienced staff.
Every study undergoes independent ethics review before it begins, participants are screened against strict eligibility criteria, and patients are closely monitored by experienced physicians and research staff throughout. All studies are conducted in an audit-ready environment that is compliant with Health Canada regulations, Good Clinical Practice standards and sponsor requirements.
Industry-sponsored and investigator-initiated trials across a broad range of dermatologic indications, with experience in every phase: Phase I safety studies, Phase II dose-finding and efficacy trials, Phase III confirmatory trials and Phase IV post-marketing observational studies. Operations run on eCTMS, eSource and eDocs platforms with full support for remote monitoring, and all regulatory work, including local and central ethics submissions, is managed in house.
Sponsors get a fully integrated, multi-site network with centralized oversight, standardized systems for regulatory submissions, data collection and quality control, and access to diverse patient populations across multiple regions. Start with the Sponsors page, or send a note through the form below and the research team will follow up.
Patients, physicians and sponsors can reach the Clinical Trials Department through the form below. A member of the research team will connect with you, answer your questions and, for patients, arrange an initial pre-screening discussion to assess eligibility for current or upcoming studies.
This page provides general information about clinical research at Rejuvenation Dermatology. Participation in any study is voluntary and subject to that study’s protocol and eligibility criteria, which are confirmed by the study team. All studies undergo independent ethics review before they begin and are conducted in accordance with Health Canada regulations and Good Clinical Practice standards.
Rejuvenation Dermatology’s Clinical Trials Department is a national, multi-site research network dedicated to advancing dermatologic care through ethically conducted, regulated clinical research. Integrated within routine clinical practice, the department partners with global pharmaceutical sponsors to evaluate novel therapies and offers early access to innovative treatment options. The team supports industry-sponsored and investigator-initiated trials across a broad range of indications, collaborating closely with sponsors, CROs, investigators, and ethics boards to deliver high-quality data while maintaining a strong commitment to patient safety.
Since its inception, the division has evolved from a single research-focused clinic into a coordinated, multi-province research network. Today, it operates with standardized infrastructure, centralized oversight, and experienced investigators across Canada.
